Blueprint MedTech Cycle 3 Announcement - CIMIT MAIN

Responsive Image

We are thrilled to announce that we’ve been selected as one of the first spokes of the ARPA-H Investor Catalyst Hub network!

We are excited to be a part of this nationwide network dedicated to accelerating groundbreaking advances in science and medicine—all in pursuit of better health outcomes for everyone.

Learn more >

Funding Opportunities and Events

News and Annoucements

null Blueprint MedTech Cycle 3 Announcement

Funding Opportunity: Blueprint MedTech Summer Award Competition

CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are accepting pre-proposals from academic and industry applicants who have emerging preventative, therapeutic, or diagnostic medical devices focused on disorders of the nervous system. 

Awards up to $500K will be made available to the most promising and innovative neurotechnologies to help accelerate their development toward commercialization. 

A major emphasis of this program is to create opportunities for diverse innovators, including those who have been traditionally underrepresented in the neurotech space. 

Program Details: 

  • Awards up to $500K to help support development toward commercialization 

  • Mentorship from experienced MedTech commercialization experts 

  • Support to address business, regulatory, clinical, and technical project areas 

Pre-proposals are due no later than August 27th, 2023. 

Learn more or Apply >  
Register for an Informational Webinar > 

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.